Senate Finance Democrats Focus on Drug Pricing Ahead of Midterms
On February 4, 2026, Senate Finance Democrats put a spotlight on rising drug costs ahead of the midterms, pushing reforms aimed at lowering prescription prices and increasing transparency, while President Trump prepared to launch a new website, TrumpRx, allowing Americans to buy medicines directly from manufacturers at discounted rates.
White House Releases "The Great Healthcare Plan" Amid Tense Affordable Healthcare Act Negotiations
On January 15, 2026, the White House rolled out President Donald Trump’s “Great Healthcare Plan,” framing it as a cost-cutting package that would lower drug prices, reduce insurance premiums, and force more transparency from insurers and providers.
Medicare Opens Drug Price Negotiation Period
On February 1, drugmakers received initial offers for how much Medicare is willing to pay for their medicines, kicking off drug price negotiations for the first time. Companies have one month to counteroffer.
HHS Announces Medicare Price Negotiation List
On August 29, the Department of Health and Human Services (HHS) announced for the first time ever ten drugs selected for Medicare price negotiation. Read the list and HHS’s future plans here.
Medicare to Release Drug Price Negotiation List, Drug Giants Respond
The Biden administration is preparing to announce the first 10 medicines it will target under a program that allows the government to negotiate drug prices with pharmaceutical giants.